TEO Therapeutics Incorporated

Hillsboro, OR Doing business as TEO Therapeutics Inc.

UEI
GY78PFFRD2V7
CAGE
9N8M2
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
9025 NE Von Neumann Dr #110, Hillsboro, OR 97006, USA
Website
teotherapeutics.com
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

TEO Therapeutics Incorporated's latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Reimagining pharmaceutical drug development in oncology with a biomimetic platform - summary more efficient processes… Grant · R43OD037620 Aggregate Financial Assistance Data $0

Quick answers

What is TEO Therapeutics Incorporated's UEI?

TEO Therapeutics Incorporated's Unique Entity ID (UEI) in SAM.gov is GY78PFFRD2V7.

What is TEO Therapeutics Incorporated's CAGE code?

TEO Therapeutics Incorporated's CAGE code is 9N8M2.

What is TEO Therapeutics Incorporated's primary NAICS code?

TEO Therapeutics Incorporated's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is TEO Therapeutics Incorporated located?

TEO Therapeutics Incorporated's physical address in SAM.gov is 9025 NE Von Neumann Dr #110, Hillsboro, OR 97006, USA.

Is TEO Therapeutics Incorporated registered in SAM.gov?

Yes. TEO Therapeutics Incorporated's SAM.gov registration is active through June 22, 2027.

What is TEO Therapeutics Incorporated's most recent federal award?

TEO Therapeutics Incorporated's most recent federal grant award is Reimagining pharmaceutical drug development in oncology with a biomimetic platform - summary more efficient processes… (R43OD037620), from Aggregate Financial Assistance Data, on September 1, 2024.

On GovTribe

See TEO Therapeutics Incorporated's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login